H.R. 7953
To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.
Session
119th Congress Current
Status Pending
Referred to the House Committee on Energy and Commerce.Sponsors (2)
PSPete Sessions
Republican · Primary
SPScott Peters
Democrat · Primary
Legislative Votes
No votes have been held on this legislation yet.